Related Experiment Video
Updated: Jun 24, 2025
11:44
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
7.6K
MicroRNAs and angiosarcoma: are there promising reports?
Amir Modarresi Chahardehi1, Arya Afrooghe2, Nikoo Emtiazi3
1Kimia Andisheh Teb Medical and Molecular Research Laboratory Co., Tehran, Iran.
Frontiers in Oncology
|June 3, 2024
Summary
MicroRNAs (miRNAs) are crucial in cardiovascular tumor development, particularly angiosarcoma. Further research is needed to compare miRNA-based diagnostics and treatments with current methods for better clinical application.
Area of Science:
- Oncology
- Molecular Biology
- Cardiovascular Research
Background:
- MicroRNAs (miRNAs) are increasingly recognized for their roles as oncogenes or tumor suppressors in cancer.
- Angiosarcoma and other cardiovascular tumors exhibit altered miRNA expression profiles, indicating their involvement in tumor genesis.
Purpose of the Study:
- To review the current literature on miRNAs in cardiovascular malignancies, focusing on angiosarcoma.
- To explore the diagnostic, prognostic, and therapeutic potential of miRNAs in angiosarcoma and related tumors.
Main Methods:
- Comprehensive literature review of studies on miRNAs in angiosarcoma and cardiovascular tumors.
- Analysis of miRNA roles in risk factors and molecular pathogenesis.
Main Results:
- Evidence supports the significant involvement of miRNAs in the pathogenesis of angiosarcoma and certain cardiovascular tumors.
- MiRNAs show promise for diagnostic, prognostic, and therapeutic applications in these malignancies.
Conclusions:
- MiRNAs offer potential for advancing the diagnosis, prognosis, and treatment of angiosarcoma and cardiovascular tumors.
- Further research is essential to compare miRNA-based approaches with existing methods and facilitate clinical translation.
